SG11201907914QA - Polypeptide, polypeptide fragment, derivative thereof, and applications thereof - Google Patents

Polypeptide, polypeptide fragment, derivative thereof, and applications thereof

Info

Publication number
SG11201907914QA
SG11201907914QA SG11201907914QA SG11201907914QA SG11201907914QA SG 11201907914Q A SG11201907914Q A SG 11201907914QA SG 11201907914Q A SG11201907914Q A SG 11201907914QA SG 11201907914Q A SG11201907914Q A SG 11201907914QA SG 11201907914Q A SG11201907914Q A SG 11201907914QA
Authority
SG
Singapore
Prior art keywords
polypeptide
derivative
applications
fragment
polypeptide fragment
Prior art date
Application number
SG11201907914QA
Other languages
English (en)
Inventor
De Wei
Yi Ding
Xiaomei Li
Wen Yu
Xiaohong Chen
Ling Xiao
Rui Chen
Ling Chen
Original Assignee
Chengdu Huitai Biomedicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201710115604.4A external-priority patent/CN106860855B/zh
Priority claimed from CN201710677602.4A external-priority patent/CN109384830B/zh
Application filed by Chengdu Huitai Biomedicine Co Ltd filed Critical Chengdu Huitai Biomedicine Co Ltd
Publication of SG11201907914QA publication Critical patent/SG11201907914QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG11201907914QA 2017-03-01 2018-02-28 Polypeptide, polypeptide fragment, derivative thereof, and applications thereof SG11201907914QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710115604.4A CN106860855B (zh) 2017-03-01 2017-03-01 多肽及多肽衍生物在预防和治疗纤维化疾病中的应用
CN201710677602.4A CN109384830B (zh) 2017-08-09 2017-08-09 多肽、多肽片段及其衍生物在防治纤维化疾病中的应用
PCT/CN2018/077492 WO2018157807A1 (zh) 2017-03-01 2018-02-28 多肽、多肽片段及其衍生物与应用

Publications (1)

Publication Number Publication Date
SG11201907914QA true SG11201907914QA (en) 2019-09-27

Family

ID=63369746

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907914QA SG11201907914QA (en) 2017-03-01 2018-02-28 Polypeptide, polypeptide fragment, derivative thereof, and applications thereof

Country Status (9)

Country Link
US (1) US12011475B2 (zh)
EP (1) EP3590527A4 (zh)
JP (1) JP6965362B2 (zh)
KR (1) KR102368159B1 (zh)
AU (1) AU2018227737B2 (zh)
CA (1) CA3054839C (zh)
IL (1) IL268971B2 (zh)
SG (1) SG11201907914QA (zh)
WO (1) WO2018157807A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108368043B (zh) * 2015-10-27 2022-11-29 台北医学大学 用于治疗及/或预防纤维化疾病的吲哚啉衍生物
CN112386678B (zh) * 2019-08-13 2023-07-07 成都惠泰生物医药有限公司 多肽或其衍生物的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9509957D0 (en) * 1995-05-17 1995-07-12 Khalil Nasreen Post-translational activation of tgf-›1 involving the tsp-1 receptor cd36
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
EP1591453A1 (en) 1999-05-17 2005-11-02 ConjuChem Inc. Modified peptides yy and conjugates thereof
CN1620309A (zh) 2001-12-18 2005-05-25 蒙多生物技术实验室 用于结合分子诊断法改进间质性肺疾病的治疗的干扰素γ或甲苯吡啶酮的新型药物组合物
WO2009033792A2 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
WO2009043525A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of the combination of gluten exorphin c and cd36 as a therapeutic agent
CA2817183A1 (en) * 2010-11-24 2012-05-31 F. Hoffmann-La Roche Ag Methods for detecting low grade inflammation
KR102577578B1 (ko) 2011-06-03 2023-09-11 조마 테크놀로지 리미티드 Tgf-베타에 특이적인 항체
WO2016054114A1 (en) * 2014-09-29 2016-04-07 The Regents Of The University Of California Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions
CN104313028A (zh) * 2014-09-30 2015-01-28 北京生科东方科技有限公司 抗类风湿关节炎的小肽基因及其生产方法
CN105061600A (zh) * 2015-09-05 2015-11-18 苏州普罗达生物科技有限公司 类风湿因子IgA抑制多肽及其应用
CN106860855B (zh) * 2017-03-01 2021-06-11 成都惠泰生物医药有限公司 多肽及多肽衍生物在预防和治疗纤维化疾病中的应用

Also Published As

Publication number Publication date
EP3590527A1 (en) 2020-01-08
AU2018227737A1 (en) 2019-10-17
KR102368159B1 (ko) 2022-03-03
JP6965362B2 (ja) 2021-11-10
CA3054839C (en) 2023-08-29
JP2020509061A (ja) 2020-03-26
IL268971B1 (en) 2023-09-01
US20220072082A1 (en) 2022-03-10
KR20190125373A (ko) 2019-11-06
IL268971A (en) 2019-10-31
CA3054839A1 (en) 2018-09-07
IL268971B2 (en) 2024-01-01
EP3590527A4 (en) 2021-01-06
WO2018157807A1 (zh) 2018-09-07
AU2018227737A2 (en) 2020-01-30
AU2018227737B2 (en) 2021-04-01
US12011475B2 (en) 2024-06-18

Similar Documents

Publication Publication Date Title
CY1124309T1 (el) Τροποποιημενα πολυπεπτιδια fgf-21 και χρησεις εξ αυτων
MX2018005720A (es) Anticuerpos pd-l1, fragmento de union al antigeno del mismo, y aplicacion medica de ello.
PH12018500586A1 (en) Farnesoid x receptor agonists and uses thereof
PH12019502058A1 (en) Farnesoid x receptor agonists and uses thereof
SA518400356B1 (ar) مثبطات الأرجيناز واستخداماتها العلاجية
NZ735044A (en) Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
IN2014MU00303A (zh)
PH12016501841A1 (en) Immunosuppressant formulation
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
EP3625245A4 (en) PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND THEIR USES IN THE TREATMENT OF INFLAMMATORY DISEASES
NZ728401A (en) High purity oritavancin and method of producing same
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
PH12018501455A1 (en) Therapeutic compostions and methods for treating hepatitis b
TW201713686A (en) Methods for preparing modified von Willebrand factor
WO2018132696A3 (en) Stomach acid-stable and mucin-binding protein-polymer conjugates
EP3205661A4 (en) Hsp70-derived peptide, and method of manufacturing pharmaceutical composition, immunity inducer, and antigen-presenting cell for cancer treatment or prevention using the same
MX2020013389A (es) Composiciones de terlipresina y usos de las mismas.
SG11201907914QA (en) Polypeptide, polypeptide fragment, derivative thereof, and applications thereof
PH12018501758A1 (en) Oritavancin formulations
EP3626727A4 (en) COMPOUND, INTERMEDIATE SYNTHESIS, USE, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC METHOD OF NEUROMODULATION
WO2018183692A8 (en) VECTORS AND COMPOSITIONS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
IL277632A (en) CDNF fragments from the carboxyl end, pharmaceutical compositions containing them and their uses
WO2019036725A3 (en) PEPTIDE INHIBITORS OF TAU AGGREGATION